VCP also correlates with increasing recurrence and poor prognosis in patients with various cancers [59–65], and very recent studies have shown that its inhibition in osteosarcoma results in loss of malignancy and decreased metastasis [66–68]. The gene discussed is VCP; the disease is osteosarcoma.